• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli companies.

    Shavit Capital has over $200 million under management across four separate private equity funds. Shavit Capital was founded in 2008 and the fourth fund was raised in 2017.  These Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Israeli Drugmaker Foamix Spots Lucrative Gap in Acne Market
    December 19, 2016
    Foamix Completes Patient Enrollment in Phase 3 Acne Trials
    November 28, 2016
    Intec Enters into Agreement with Michael J. Fox Foundation
    November 28, 2016
    Foamix Reports Q3 2016 Financial Results and Provides Business Update
    November 16, 2016
    Drug release co PolyPid raises $5.3m
    November 10, 2016
    Foamix Announces Pricing of its $57 Million Follow-on Offering
    September 28, 2016
    Foamix Announces Positive Topline Results from Phase 2 Trial Evaluating FMX-1
    September 12, 2016
    ReWalk Exoskeleton Deemed Necessary as Medical Aid
    August 4, 2016
    ReWalk Reports Second Quarter 2016 Financial Results
    August 4, 2016
    Intec Pharma to Pursue Development of Accordion Pill for Cannabinoid Therapie
    August 4, 2016